Archer C, Randhawa M, Kim H, et al. Real world data on intensive follow-up for stage IV metastatic melanoma patients receiving ipilimumab and nivolumab: a safer model of care? SMR 2017, abstract P07-1.
Adjuvant ipilimumab bij stadium III-melanoom
jan 2017 | Dermato-oncologie, Immuuntherapie